The gold standard for bloodstream infection (BSI) diagnostics involves culturing positive blood cultures (BCs) using phenotypic methods for organism identification and antimicrobial resistance (AMR) testing, which can take up to five days. However, it is crucial to optimize antimicrobial therapy as soon as possible to reduce morbidity and mortality. We present a novel laboratory and bioinformatic workflow to rapidly identify bacterial and fungal organisms and AMR determinants from positive BCs using Oxford Nanopore Technologies long-read sequencing. Using a robust clinical sample size ( n =307), after a BC has flagged positive, our average turnaround time from DNA extraction to determination of species identity was 4.4 h for a multiplex run of 12 BCs and 3.7 h for a single sample run. We demonstrated that our pipeline taxonomic species identification results agreed with conventional MALDI-TOF identification for almost all positive BCs (97.7%, 300/307). Most species were accurately identified within the first hour of sequencing (93.7%, 281/300). We explored AMR detection for clinically relevant antimicrobials and observed that assembly-based tools had higher agreement to conventional antimicrobial susceptibility testing (AST) (81.2% after 1 h of sequencing, 89.6% after 5 h of sequencing) than read-based tools. Finally, we developed a publicly available analysis pipeline ( venae ) that generates a clinician-friendly HTML report, is quick to run and can dynamically update as more sequencing data is acquired. This study demonstrates how applying rapid, real-time genomics to BSI diagnostics can support clinical decision-making and improve patient outcomes by reducing turnaround times.
Lerminiaux et al. (Thu,) studied this question.